Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer"
NCT01976910
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
DM-CHOC-PEN
Sponsor
DEKK-TEC, Inc.
Collaborators
[object Object]